GOELTZ II ROBERT C. (Chief Financial Officer) sold 8.4% of their position (7.76K shares) of ARCUS BIOSCIENCES, INC. on the open market
Open‑market sale worth $199.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/12/2026ACC: 0001653881-26-000005
Officer· Chief Financial Officer
Since Aug 2020
-7.76K
Net shares
Net seller
$199.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
7.76K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−7.76K
Price / share
$25.63
Trade value
$198.97K
% of position
8.4%
5/11/2026
91.92K→84.16K
Total
Net shares
−7.76K
Net value
-$198.97K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/11/2026 | S · Sale | −7.76K | $25.63 | $198.97K | 8.4% | 91.92K | 84.16K |
| Total | −7.76K | -$198.97K | ||||||
Derivative Transactions0
No derivative transactions reported